Condition
Submucosal Tumor of Gastrointestinal Tract
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed1
Terminated1
Enrolling By Invitation1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07550582Phase 2Enrolling By InvitationPrimary
Mesenteric Vascular Preconditioning Combined With Laparoscopic and Endoscopic Cooperative Surgery for Submucosal Tumor at the Gastroesophageal Junction
NCT05394129TerminatedPrimary
Diagnostic Accuracy of SurePath™ in EUS-FNA
NCT06340620Not ApplicableRecruiting
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
NCT03321396Not ApplicableCompletedPrimary
Hydrogel Injection to Assist Endoscopic Submucosal Dissection
Showing all 4 trials